[石油加工、炼焦和核燃料加工业] [2020-01-10]
2019年1-9月,我国石油和化工行业运行呈现以下特征。一是石油和化工行业固定资产投资保持增长态势。二是生产保持平稳。
[汽车制造业] [2020-01-10]
分析内容中的资料和数据来源于对行业公开信息的分析、对业内资深人士和相关企业高管的深度访谈,以及易观分析师综合以上内容作出的专业性判断和评价。
[信息传输、软件和信息技术服务业] [2020-01-10]
软件业务收入保持较快增长。前三季度,我国软件业完成软件业务收入51896亿元,同比增长15.2%,增速同比提高0.2个百分点。
[信息传输、软件和信息技术服务业] [2020-01-10]
今年1-8月,我国软件和信息技术服务业保持平稳发展趋势,业务收入较快增长,利润总额增速放缓。
[汽车制造业] [2020-01-10]
分析内容中的资料和数据来源于对行业公开信息的分析、对业内资深人士和相关企业高管的深度访谈,以及易观分析师综合以上内容作出的专业性判断和评价。
[金融业] [2020-01-10]
[金融业] [2020-01-10]
[电力、热力、燃气及水生产和供应业] [2020-01-10]
国家能源局日前发布了关于对《电力业务许可证涉及的部分拟保留证明事项清单》公开征求意见的公告,按照证明事项清理工作要求,现将电力业务许可证涉及的部分拟保留证明事项向社会公开征求意见。
[信息传输、软件和信息技术服务业,医药制造业] [2020-01-10]
Evidence-based research studies on healthcare technologies indicated that the adoption of patient portals reached 90% in most of the developed countries. This means, 90% of the providers offer patient portals to their patients in the United States. However, there are still some unmet needs of the patients that require more actions, in order to drive the effective use of patient portals across the developing countries. Despite the higher adoption rate of patient portals, the number of patients that use the portal to take care of their health is low. According to a report published by the American Hospital Association (AHA), only 30% of the patients in the United States actively use patient portal. The scenario is similar in the European countries, such as Germany and France, where the adoption is higher, but the actual use is yet to reach the satisfactory percentage.
[医药制造业] [2020-01-10]
Orphan drugs can be defined as a molecule intended to treat a rare disease. The rare disease, as name suggests, has low prevalence rate and has been defined differently across the geographical locations. Each country has at the least one organization, which has been supporting the patients suffering from rare diseases. The need is to generate enough orphan drugs’ availability to the needful for the intended treatment, across the world. From the company's perspective, there is increased focus by drug manufacturers, each year, on the development of therapies for orphan indications, as well as, explore the expansion opportunities across the world. The market report discusses the market aspects related to each market, segmentation, and major geographies across world. The market size can be evaluated by collating the revenues generated from various segments and their usage across the various end-user industries, along with the costs associated with products. The definitions for individual segments have been provided in the respective segments. The market estimates provided in this report are entirely based on the segments tracked in this report.